MmD patients carrying mutations in RYR1 typically present with extraocular muscle involvement and ophthalmoplegia, symptoms not observed in patients with mutations in SEPN1, which are present in the majority of MmD cases (Villar-Quiles et al., 2020). This evidence concerns the gene SELENON and multiminicore myopathy.